Literature DB >> 80411

Modified Grocott's methenamine silver nitrate method for quick staining of Pneumocystis carinii.

R L Pintozzi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 80411      PMCID: PMC1145410          DOI: 10.1136/jcp.31.8.803

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  6 in total

1.  A NEW PROCEDURE FOR THE IDENTIFICATION OF PNEUMOCYSTIS CARINII CYSTS IN TISSUE SECTIONS AND SMEARS.

Authors:  A M CHALVARDJIAN; L A GRAWE
Journal:  J Clin Pathol       Date:  1963-07       Impact factor: 3.411

2.  A stain for fungi in tissue sections and smears using Gomori's methenamine-silver nitrate technic.

Authors:  R G GROCOTT
Journal:  Am J Clin Pathol       Date:  1955-08       Impact factor: 2.493

3.  A rapid staining technique for Pneumocystis carinii.

Authors:  J W Smith; W T Hughes
Journal:  J Clin Pathol       Date:  1972-03       Impact factor: 3.411

4.  Rapid Grocott's methenamine--silver nitrate method for fungi and Pneumocystis carinii.

Authors:  C J Churukian; E A Schenk
Journal:  Am J Clin Pathol       Date:  1977-09       Impact factor: 2.493

5.  Studies of morphology and immunofluorescence of Pneumocystis carinii.

Authors:  H K Kim; W T Hughes; S Feldman
Journal:  Proc Soc Exp Biol Med       Date:  1972-10

6.  Pneumocystis carinii pneumonia. Diagnosis by lung biopsy.

Authors:  P P Rosen; N Martini; D Armstrong
Journal:  Am J Med       Date:  1975-06       Impact factor: 4.965

  6 in total
  11 in total

Review 1.  Pneumocystis carinii, an opportunist in immunocompromised patients.

Authors:  M S Bartlett; J W Smith
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

2.  Simultaneous demonstration of cyst walls and intracystic bodies of Pneumocystis carinii in paraffin embedded lung sections using Gomori's methenamine silver nitrate and Giemsa stain.

Authors:  T Shiota
Journal:  J Clin Pathol       Date:  1986-11       Impact factor: 3.411

3.  Pneumocystis carinii in bronchoalveolar lavage.

Authors:  G M Campbell; J McCorriston
Journal:  J Clin Pathol       Date:  1987-03       Impact factor: 3.411

4.  Techniques for examining Pneumocystis carinii in fresh specimens.

Authors:  J J Ruffolo; M T Cushion; P D Walzer
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

5.  Laboratory diagnosis of pulmonary toxoplasmosis in patients with acquired immunodeficiency syndrome.

Authors:  F Derouin; C Sarfati; B Beauvais; M C Iliou; L Dehen; M Lariviere
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

6.  Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice.

Authors:  A G Harmsen; M Stankiewicz
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

7.  New Grocott Stain without Using Chromic Acid.

Authors:  Kazuya Shiogama; Kayo Kitazawa; Yasuyoshi Mizutani; Takanori Onouchi; Ken-Ichi Inada; Yutaka Tsutsumi
Journal:  Acta Histochem Cytochem       Date:  2015-02-03       Impact factor: 1.938

8.  Three-dimensional ultrastructural study of the anther of Silene latifolia infected with Microbotryum lychnidis-dioicae.

Authors:  Hiroki Kawamoto; Aiko Hirata; Shigeyuki Kawano
Journal:  PLoS One       Date:  2017-08-09       Impact factor: 3.240

9.  Pneumocystis jirovecii can be productively cultured in differentiated CuFi-8 airway cells.

Authors:  Verena Schildgen; Stephanie Mai; Soumaya Khalfaoui; Jessica Lüsebrink; Monika Pieper; Ramona L Tillmann; Michael Brockmann; Oliver Schildgen
Journal:  mBio       Date:  2014-05-13       Impact factor: 7.867

10.  High-Throughput Microdissection for Next-Generation Sequencing.

Authors:  Avi Z Rosenberg; Michael D Armani; Patricia A Fetsch; Liqiang Xi; Tina Thu Pham; Mark Raffeld; Yun Chen; Neil O'Flaherty; Rebecca Stussman; Adele R Blackler; Qiang Du; Jeffrey C Hanson; Mark J Roth; Armando C Filie; Michael H Roh; Michael R Emmert-Buck; Jason D Hipp; Michael A Tangrea
Journal:  PLoS One       Date:  2016-03-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.